Buscar resultados de ensayos clínicos
Liposarcoma - 50 Studies Found
Estado | Estudiar |
Withdrawn |
Nombre del estudio: Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma Condición: Dedifferentiated Liposarcoma Fecha: 2009-09-01 Intervenciones: Drug: IPI-504 IPI 504 administered twice weekly at 225 mg/m2 for 2 weeks followed by 1 week off treatmen |
Active, not recruiting |
Nombre del estudio: Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial Condición: Advanced and / or Metastatic Liposarcoma Fecha: 2012-09-14 Intervenciones: Drug: Pazopanib Patients will receive oral pazopanib, 800mg once daily and treatment will continue until |
Recruiting |
Nombre del estudio: Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma Condición:
Fecha: 2014-09-05 Intervenciones: Drug: Trabectedin Trabectedin administered at a dose of 1.5 mg/m2 - 1.3 mg/m2 (at investigator's discret |
Completed |
Nombre del estudio: A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma Condición: Advanced Liposarcoma or Leiomyosarcoma Fecha: 2011-04-26 Intervenciones:
|
Recruiting |
Nombre del estudio: A Pilot Study of NY-ESO-1ᶜ²⁵⁹T Cells in Subjects With Advanced Myxoid/ Round Cell Liposarcoma Condición:
|
Terminated |
Nombre del estudio: Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial Condición: Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma Fecha: 2012-10-29 Intervenciones: Drug: plitidepsin |
Completed |
Nombre del estudio: PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma Condición:
Fecha: 2010-09-24 Intervenciones: Drug: Palbociclib Treatment will consist of either: |
Recruiting |
Nombre del estudio: Study of Abemaciclib in Dedifferentiated Liposarcoma Condición:
Fecha: 2016-07-25 Intervenciones: Drug: Abemaciclib Other Name: LY2835219 |
Active, not recruiting |
Nombre del estudio: A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma Condición:
Fecha: 2015-10-06 Intervenciones: Drug: ribociclib Oral, 600 mg x 1 a day, duration - according to response |